ImmunoGen Inc (IMGN.OQ) Key Developments | Reuters.com
Edition:
United States

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

3.13USD
24 Jun 2016
Change (% chg)

$-0.19 (-5.72%)
Prev Close
$3.32
Open
$3.19
Day's High
$3.27
Day's Low
$3.12
Volume
514,326
Avg. Vol
495,167
52-wk High
$19.42
52-wk Low
$3.12

Latest Key Developments (Source: Significant Developments)

ImmunoGen Inc reaffirms FY 2015 outlook
Friday, 30 Jan 2015 06:30am EST 

ImmunoGen Inc:Says its financial guidance remains unchanged from that issued in Oct. 2014.Expects FY 2015 revenues to be between $100 mln and $105 mln.Expects FY 2015 net loss to be between $60 mln and $65 mln.FY 2015 net profit of ($60) mln - Thomson Reuters I/B/E/S.  Full Article

ImmunoGen Inc reaffirms FY 2015 guidance
Friday, 24 Oct 2014 06:30am EDT 

ImmunoGen Inc:Says that its financial guidance remains unchanged from that issued in Aug.Expects FY 2015 revenues to be between $100 million and $105 million.Expects FY 2015 net loss to be between $60 million and $65 million.FY 2015 revenue of $101 million and net loss of $64 million - Thomson Reuters I/B/E/S.  Full Article

ImmunoGen Inc reaffirms FY 2015 revenue guidance - Conference Call
Monday, 8 Sep 2014 09:55am EDT 

ImmunoGen Inc:Says revenues for FY 2015 should be in the $100 million to $105 million range.  Full Article

ImmunoGen Inc gives FY 2015 guidance above analysts' estimates
Friday, 1 Aug 2014 06:30am EDT 

ImmunoGen Inc:Expects FY 2015 revenues to be between $100 mln and $105 mln.Expects FY 2015 net loss to be between $60 mln and $65 mln.FY 2015 revenue of $71 mln and net income of $(78) mln - Thomson Reuters I/B/E/S.  Full Article

BRIEF-ImmunoGen announces pricing of $100 mln offering of Senior Notes

* Sale of notes is expected to result in $96.7 million net proceeds to Immunogen